Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Novel therapies, improved technologies and a better understanding of the immune system could yield broad dividends.
Often misdiagnosed. Almost always misunderstood. Alzheimer research is plagued with both myopic thinking and a vexing natural history.
Alzheimer’s advocates laud the approval of Aduhelm, but experts raise questions about its effectiveness and cost.
Excess weight, which is often linked to metabolic abnormalities, can contribute to a wide variety of health problems.
A new analysis suggests that the impact of HIV-associated neurocognitive disorders differs by sex, race, age and employment status.
Going hungry for a prolonged period raised the risk of declining mental performance.
In the context of universal health care, this may be a result of more frequent access to care.
In a well-insured cohort of older people with HIV, antiretroviral treatment didn’t offset the risk for dementia.
Sudden cognitive dysfunction is a common concern for seniors who’ve survived a serious bout of COVID-19.
While people with HIV have a higher rate of early Alzheimer’s than those without the virus, treatment appears to eliminate this excess risk.
A recent study of veterans found that antiretroviral treatment was not associated with a mitigated dementia risk.
A $7 million grant goes to new research seeking insights to neurological and cognitive problems.
HIV leads to brain inflammation and cognitive decline, but adding marijuana to the mix doesn’t seem to further such damage.
Factors associated with a higher risk of impairment include depression, poor adherence to antiretrovirals and opportunistic infections.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.